You have 9 free searches left this month | for more free features.

Selectin Inhibitor

Showing 1 - 25 of 7,510

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Pneumonia Trial in Ann Arbor (Uproleselan)

Recruiting
  • COVID-19 Pneumonia
  • Ann Arbor, Michigan
    The University of Michigan
Dec 6, 2021

Sickle Cell Disease Trial in Oakland, Sacramento, Durham (GMI-1070)

Completed
  • Sickle Cell Disease
  • Oakland, California
  • +2 more
May 7, 2020

sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

Completed
  • Chronic Myeloid Leukemia
  • ELISA kit
  • Tanta, Egypt
    Tanta University
May 18, 2022

Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis Trial in Canada, United States (GMI-1070, Placebo)

Completed
  • Sickle Cell Disease
  • +2 more
  • Birmingham, Alabama
  • +21 more
May 7, 2020

Urologic Diseases, Erectile Dysfunction With Diabetes Trial in Jakarta Pusat (stem cells, )

Recruiting
  • Urologic Diseases
  • Erectile Dysfunction With Diabetes Mellitus
  • stem cells
  • placebo
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Universitas Indonesia
Mar 28, 2022

Subclinical Impairment of Cardiovascular System in Psoriasis

Completed
  • Psoriasis
  • +6 more
    • Ljubljana, Slovenia
      University Medical Centre Ljubljana
    Jul 19, 2023

    Clearance of Vasoactive Metabolites With Blood Purification

    Not yet recruiting
    • Critically Ill Patients
      • Garches, France
      • +1 more
      Oct 27, 2023

      Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

      Recruiting
      • Covid19
      • theraputic heparin
      • +4 more
      • Birmingham, Alabama
      • +101 more
      Jun 28, 2022

      Cardiometabolic Health Trial in Kallithéa (Conventional fish, Enriched fish)

      Completed
      • Cardiometabolic Health
      • Conventional fish
      • Enriched fish
      • Kallithéa, Attica, Greece
        Department of Nutrition and Dietetics, School of Health Sciences
      Jun 9, 2022

      DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)

      Not yet recruiting
      • Diabetes MellitusType 1
      • Placebo
      • Alpha Lipoic Acid 600 MG Oral Capsule
      • (no location specified)
      Jan 8, 2023

      Sleep, Cardiovascular Risk Factor Trial in Portland (Regularized Sleep Schedule)

      Recruiting
      • Sleep
      • Cardiovascular Risk Factor
      • Regularized Sleep Schedule
      • Portland, Oregon
        Oregon Health and Science University
      Aug 10, 2022

      Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)

      Not yet recruiting
      • Coronary Artery Ectasia
      • Rivaroxaban 2.5 Mg Oral Tablet twice daily
      • +2 more
      • (no location specified)
      Jan 30, 2023

      Inflammation Trial in Buffalo (Pioglitazone 15mg, pioglitazone 30mg, )

      Completed
      • Inflammation
      • Pioglitazone 15mg
      • +2 more
      • Buffalo, New York
        Millard Fillmore gates Hospital
      Jan 12, 2022

      Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

      Recruiting
      • Immune Thrombocytopenia
      • Suzhou, Jiangsu, China
        Jie Yin
      Apr 19, 2022

      Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

      Completed
      • Multiple Myeloma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 22, 2022

      Developmental Endothelial Locus-1, Platelet Count, and Soluble

      Not yet recruiting
      • Overweight and Obesity
      • Platelet count
      • +2 more
      • Aswan, Egypt
        Aswan University Hospital
      May 17, 2023

      Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)

      Not yet recruiting
      • Coronary Artery Disease
      • +2 more
      • heated tobacco - lifestyle intervention
      • Warsaw, Poland
        National Institute of Cardiology
      Dec 27, 2022

      Cardiac Implantable Electronic Devices on the Hemostatic System

      Recruiting
      • Thromboembolism
      • +2 more
      • Cardiac implantable electronic device implantation.
      • +4 more
      • Ryazan', Ryazan, Russian Federation
        Ryazan State Medical University
      Oct 26, 2022

      Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)

      Terminated
      • Sickle Cell Disease
      • Birmingham, Alabama
      • +48 more
      May 9, 2022

      Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

      Not yet recruiting
      • Acute Myelogenous Leukemia
      • +2 more
      • (no location specified)
      Mar 3, 2022

      Venous Insufficiency of Leg, Venous Insufficiency (Chronic)(Peripheral), Endothelial Dysfunction Trial in Moscow (Endovenous

      Completed
      • Venous Insufficiency of Leg
      • +2 more
      • Endovenous laser ablation of great saphenous vein (GSV) and microphlebectomy of varicose veins
      • Pharmacotherapy
      • Moscow, Russian Federation
        N.I. Pirogov National Medical and Surgical Center
      Sep 3, 2021

      Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)

      Terminated
      • Severe Acute Respiratory Syndrome Coronavirus 2
      • SARS-CoV2
      • Janus Kinase Inhibitor (ruxolitinib)
      • Placebo
      • Sao Paulo, Brazil
        Hospital das Clínicas
      Apr 5, 2021

      Endometriosis Trial in Boston (norethindrone acetate (NETA), Placebo)

      Not yet recruiting
      • Endometriosis
      • norethindrone acetate (NETA)
      • Placebo
      • Boston, Massachusetts
        Boston Children's Hospital
      Sep 14, 2022